This assumption is supported by genetic data; in Lafora disease mouse models, by producing a decrease in the expression/activity of the enzyme that is in charge of glycogen synthesis in the brain, namely glycogen synthase 1 (GYS1), there was a reduction in the pathophysiological features of the disease [18,19,20]. Here, GYS1 is linked to Lafora disease.